Clinical Scorecard: Creation and assessment of a nomogram for predicting osteoporosis risk among individuals with rheumatoid arthritis

At a Glance

Key Highlights

• Developed a nomogram incorporating clinical and laboratory predictors for osteoporosis risk in RA patients.
• Independent predictors include female sex, HAQ-DI, elevated ALP, ApoA1/ApoB ratio, FFA, and lower BMI.
• Nomogram demonstrated good discrimination (AUROC 0.812 training, 0.788 validation) and calibration.
• Identified risk strata (low/medium/high) for osteoporosis in RA patients.
• Highlights the need for early screening and intervention in RA patients to prevent osteoporosis.

Guideline-Based Recommendations

Diagnosis

• Use dual-energy X-ray absorptiometry (DXA) for measuring bone mineral density.

Management

• Implement targeted screening based on nomogram results to identify high-risk RA patients.

Monitoring & Follow-up

• Regularly assess osteoporosis risk factors and bone mineral density in RA patients.

Risks

• Increased risk of fractures, disability, and mortality associated with osteoporosis in RA.

Patient & Prescribing Data

Patients diagnosed with rheumatoid arthritis, particularly those with additional risk factors for osteoporosis.

Consider integrating clinical and laboratory measures for osteoporosis risk assessment in RA management.

Clinical Best Practices

• Utilize the nomogram for osteoporosis risk stratification in RA patients.
• Encourage early intervention strategies for patients identified at high risk of osteoporosis.

Related Resources & Content

• Study on osteoporosis prevalence in RA patients
• Clinical criteria for bone densitometry in RA
• Logistic regression model for fracture risk in RA